Evaluation of in vitro drug interactions with karenitecin, a novel, highly lipophilic camptothecin derivative in phase II clinical development

Judith A. Smith, Robert A. Newman, Frederick H. Hausheer, Timothy Madden

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of in vitro drug interactions with karenitecin, a novel, highly lipophilic camptothecin derivative in phase II clinical development'. Together they form a unique fingerprint.

Medicine & Life Sciences